{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:42:44Z","timestamp":1790142164643,"version":"4.0.1"},"reference-count":31,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The adipocyte-derived hormone leptin, which plays an important role in energy homeostasis, has been suggested to have an influence on bone development and remodeling. However, it is not clear from animal studies whether leptin is a stimulator or an inhibitor of bone growth. Cross-sectional studies in humans suggest that serum leptin levels are positively associated with bone mineral density (BMD), but these observations are not consistent, and whether this relationship is independent of obesity remains unclear. We therefore examined the effect of sc leptin administration on BMD and markers of bone turnover in two women, one with congenital generalized lipodystrophy and the other with acquired generalized lipodystrophy. Both patients had regular menstrual cycles. At baseline, the BMD for both patients, measured at the lumbar spine and total hip, was within 1 sd of the peak bone mass. There was no significant change in BMD in both patients after 16\u201318 months of leptin therapy. Similarly, concentrations of serum osteocalcin and bone-specific alkaline phosphatase or urinary excretion of deoxypyridinoline and N-telopeptides remained unchanged after 6\u20138 months of leptin therapy, suggesting no effects of leptin on osteoblastic or osteoclastic activity. Our preliminary data suggest that sc leptin replacement in hypoleptinemic patients with generalized lipodystrophy has no effect on the mature adult skeleton.<\/jats:p>","DOI":"10.1210\/jc.2002-020792","type":"journal-article","created":{"date-parts":[[2002,11,2]],"date-time":"2002-11-02T03:22:01Z","timestamp":1036207321000},"page":"4942-4945","source":"Crossref","is-referenced-by-count":37,"title":["Effect of Subcutaneous Leptin Replacement Therapy on Bone Metabolism in Patients with Generalized Lipodystrophy"],"prefix":"10.1210","volume":"87","author":[{"given":"Vinaya","family":"Simha","sequence":"first","affiliation":[{"name":"Division of Nutrition and Metabolic Diseases, Center for Human Nutrition (V.S., A.G.), Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Zerwekh","sequence":"additional","affiliation":[{"name":"Division of Mineral Metabolism (J.E.Z., K.S.), Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayar","family":"Sakhaee","sequence":"additional","affiliation":[{"name":"Division of Mineral Metabolism (J.E.Z., K.S.), Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu","family":"Garg","sequence":"additional","affiliation":[{"name":"Division of Nutrition and Metabolic Diseases, Center for Human Nutrition (V.S., A.G.), Dallas, Texas 75390"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071615451822300_R1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue.","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"2020071615451822300_R2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1126\/science.274.5290.1185","article-title":"Modulation of insulin activities by leptin.","volume":"274","author":"Cohen","year":"1996","journal-title":"Science"},{"key":"2020071615451822300_R3","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1073\/pnas.93.25.14564","article-title":"Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.","volume":"93","author":"Gainsford","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071615451822300_R4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression.","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"2020071615451822300_R5","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/endo.137.7.8770941","article-title":"Leptin is a metabolic signal to the reproductive system.","volume":"137","author":"Barash","year":"1996","journal-title":"Endocrinology"},{"key":"2020071615451822300_R6","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1126\/science.281.5383.1683","article-title":"Biological action of leptin as an angiogenic factor.","volume":"281","author":"Sierra-Honigmann","year":"1998","journal-title":"Science"},{"key":"2020071615451822300_R7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/rp.56.1.401","article-title":"Leptin controls bone formation through a hypothalamic relay.","volume":"56","author":"Karsenty","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"2020071615451822300_R8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass.","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"key":"2020071615451822300_R9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-0115(00)00152-X","article-title":"Leptin is a potent stimulator of bone growth in ob\/ob mice.","volume":"92","author":"Steppan","year":"2000","journal-title":"Regul Pept"},{"key":"2020071615451822300_R10","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1210\/endo.142.8.8346","article-title":"Leptin reduces ovariectomy-induced bone loss in rats.","volume":"142","author":"Burguera","year":"2001","journal-title":"Endocrinology"},{"key":"2020071615451822300_R11","first-page":"211","article-title":"Spine and femur density using dual-photon absorptiometry in US white women.","volume":"2","author":"Mazess","year":"1987","journal-title":"Bone Miner"},{"key":"2020071615451822300_R12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jbmr.5650070109","article-title":"Bone mass and body composition in normal women.","volume":"7","author":"Lindsay","year":"1992","journal-title":"J Bone Miner Res"},{"key":"2020071615451822300_R13","first-page":"45","article-title":"Determinants of total body and regional bone mineral density in normal postmenopausal women: a key role for fat mass.","volume":"75","author":"Reid","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615451822300_R14","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s002239900557","article-title":"Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women.","volume":"63","author":"Goulding","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"2020071615451822300_R15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S8756-3282(01)00487-2","article-title":"Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women.","volume":"29","author":"Thomas","year":"2001","journal-title":"Bone"},{"key":"2020071615451822300_R16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2265.2001.01361.x","article-title":"Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women.","volume":"55","author":"Yamauchi","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071615451822300_R17","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1210\/jcem.83.10.5204","article-title":"Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children.","volume":"83","author":"Klein","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615451822300_R18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s002239900556","article-title":"Does leptin have an effect on bone in adult women?","volume":"63","author":"Rauch","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"2020071615451822300_R19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy.","volume":"346","author":"Oral","year":"2002","journal-title":"N Engl J Med"},{"key":"2020071615451822300_R20","first-page":"358","article-title":"Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy.","volume":"75","author":"Garg","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615451822300_R21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00241817","article-title":"The skeleton in congenital, generalized lipodystrophy: evaluation using whole-body radiographic surveys, magnetic resonance imaging and technetium-99m bone scintigraphy.","volume":"21","author":"Fleckenstein","year":"1992","journal-title":"Skel Radiol"},{"key":"2020071615451822300_R22","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1210\/jcem.84.9.6103","article-title":"A gene for congenital generalized lipodystrophy maps to human chromosome 9q34.","volume":"84","author":"Garg","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615451822300_R23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"The gene encoding 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2) is mutated in congenital generalized lipodystrophy linked to chromosome 9q34.","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"2020071615451822300_R24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1210\/jcem-70-4-1007","article-title":"Effects of dietary carbohydrates on metabolism of calcium and other minerals in normal subjects and patients with noninsulin-dependent diabetes mellitus.","volume":"70","author":"Garg","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615451822300_R25","first-page":"2197","article-title":"A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women.","volume":"85","author":"Prestwood","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615451822300_R26","first-page":"3109","article-title":"Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Treatment Study Group.","volume":"85","author":"Tonino","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615451822300_R27","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"2020071615451822300_R28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/1043-2760(95)00111-T","article-title":"Anabolic effects of fluoride on bone.","volume":"6","author":"Pak","year":"1995","journal-title":"Trends Endocrinol Metab"},{"key":"2020071615451822300_R29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency.","volume":"341","author":"Farooqi","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071615451822300_R30","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1210\/jcem.85.5.6591","article-title":"The relationship between leptin concentration and bone metabolism in the human fetus.","volume":"85","author":"Ogueh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071615451822300_R31","first-page":"R2056","article-title":"Renal effects of leptin in normotensive, hypertensive, and obese rats","volume":"275","author":"Villarreal","year":"1998","journal-title":"Am J Physiol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/87\/11\/4942\/9040705\/jcem4942.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/87\/11\/4942\/9040705\/jcem4942.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T02:52:20Z","timestamp":1594954340000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/87\/11\/4942\/2823121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,1]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2002-020792","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,1]]}}}